| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP And CFO | SVP And CFO | CFO &Executive Vice President +1 more
3 companies
Dier Mardi is a CFO &Executive Vice President at Ultragenyx Pharmaceutical Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 1 buy and 24 sells.
Estimated insider holdings value: $8.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2025 | MDGL Madrigal Pharmaceuticals, Inc. | EVP And CFO | Sale+OE | 4,173 | $578.34 | $2,413,416.41 | -2.3% | -24.0% | - | |
| Mar 10, 2025 | MDGL Madrigal Pharmaceuticals, Inc. | SVP And CFO | Sell | 258 | $323.04 | $83,344.32 | -2.4% | -14.9% | +31.5% | |
| Mar 3, 2025 | MDGL Madrigal Pharmaceuticals, Inc. | SVP And CFO | Sell | 1,961 | $324.96 | $637,248.06 | -11.8% | -13.0% | +35.9% | |
| Oct 14, 2022 | RARE Ultragenyx Pharmaceutical Inc. | CFO &Executive Vice President | Sell | 1,629 | $40.16 | $65,420.64 | -2.4% | +16.5% | -9.4% | |
| Oct 12, 2022 | RARE Ultragenyx Pharmaceutical Inc. | CFO &Executive Vice President | Sell | 3,484 | $38.22 | $133,158.48 | -4.9% | +12.9% | -15.2% | |
| Mar 3, 2022 | RARE Ultragenyx Pharmaceutical Inc. | CFO &Executive Vice President | Sell | 954 | $65.71 | $62,686.08 | -1.0% | -28.0% | -28.7% | |
| Oct 14, 2021 | RARE Ultragenyx Pharmaceutical Inc. | CFO &Executive Vice President | Sell | 6,738 | $82.00 | $552,523.59 | -7.7% | -12.1% | -54.2% | |
| Sep 29, 2020 | PRLD Prelude Therapeutics Inc | Director | Buy | 10,000 | $19.00 | $190,000.00 | New | - | - |